The IPO Buzz: Aktis Oncology Prices IPO at $18 – High End – 1st Big IPO of ’26 Pops on NASDAQ
Aktis Oncology (AKTS) priced its recently upsized IPO at $18.00 – the top of its $16.00-to-$18.00 range – and sold 17.65 million shares – the number of shares in the prospectus – to raise $317.7 million on Thursday night, Jan. 8, 2026. The stock of Aktis Oncology jumped in its NASDAQ debut – opening at […]
January 8, 2026 Read More